WNT5A and posterior cortical atrophy: Although a different and more advanced PCa patient material was used by Chen and co-workers, their finding that Wnt1 and β-catenin expression can serve as markers for PCa progression [12] is compatible with our data that Wnt5a predicts a more favorable outcome in PCa patients.